Report Categories
View AllRecent Articles
View All
HRB HR Block posts smaller Q1 2026 loss than analyst forecasts shares rise modestly in todays trading
The strategic moves USCB USCB is making now Institutional Demand 20260508
RXO RXO Q4 2025 earnings miss estimates by wide margin shares slide 225 on weak investor sentiment
HHS Harte Hanks drops 143 following Q2 2025 earnings reporting a 005 per share loss
EOG Resources Surges in Q1 as Oil Prices and Operational Strength Drive Investor Optimism
ONGC Q4 FY26 Net Profit Edges Up 3 to 6650 Crore Board Declares Final Dividend
Russias GDP Growth Contradicted by Nighttime Luminosity Data Raising Concerns Among Elites
Indian Markets Edge Higher Financials Lead While Pharma Caps Gains Key Levels on Watch
Wall Street Complacency Raises Concerns About Potential Market Correction
Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil to New Highs This Summer
LLY Q1 2026 Earnings Earnings Crush Drives Modest Stock Gains as Revenue Details Remain Limited
CAKE Q1 2026 Earnings Modest EPS Beat Amidst Cautious Consumer Environment
UCB Q1 2026 Earnings EPS Slightly Misses Estimates Amid Positive Market Reaction
RDNW Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction
YELP Q1 2026 Earnings EPS Beats Estimates by 117 Stock Gains 23
Astrotech Corporation ASTC Q1 2024 Earnings Net Loss Deepens as Company Focuses on Technology Commercialization
Obsidian Energy OBE Falls Over 45 as Support Level Looms
EPAM Systems Holds Steady Above Key Support After Modest Gain
Sleep Number Corporation SNBR Bounces from Support Potential Reversal or Temporary Relief
Transocean RIG Edges Higher Amid Modest Gains Key Levels in Focus
Rockwell Automation ROK Holds Steady Near Support Amid Modest Gains
External Links
Fed Dissenters Cite Disagreement Over Rate Cut Signals in Latest Vote
BANX Q4 2022 Earnings EPS Misses Estimates Amid Market Headwinds
Liberty Live Holdings LLYVK Holds Steady Near 98 as Modest Decline Reflects Cautious Sentiment
Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline
Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances
Evercore Q1 2026 Earnings Blowout EPS Beats Estimates by 4665
Gentherm Inc THRM Q1 2026 Earnings EPS Crushes Estimates Stock Rises
TNON Q1 2026 Earnings EPS Beat Provides Optimism Amid PreRevenue Operations
Palantir Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Unavailable Stock Edges Lower
FBRX Q1 2026 Earnings Narrower Loss But Clinical Path Remains Uncertain